Radiotherapy as an immunological booster in patients with metastatic melanoma or renal cell carcinoma treated with high-dose Interleukin-2: evaluation of biomarkers of immunologic and therapeutic response

BACKGROUND: Tumor cells killed by radiation therapy (RT) are a potentially good source of antigens for dendritic cell (DC) uptake and presentation to T-cells. RT upregulates cell death receptors such as Fas/CD95 and MHC-I, induces the expression of co-stimulatory molecules on tumor cells, and promot...

Descripción completa

Detalles Bibliográficos
Autores principales: Ridolfi, Laura, de Rosa, Francesco, Ridolfi, Ruggero, Gentili, Giorgia, Valmorri, Linda, Scarpi, Emanuela, Parisi, Elisabetta, Romeo, Antonino, Guidoboni, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182814/
https://www.ncbi.nlm.nih.gov/pubmed/25245327
http://dx.doi.org/10.1186/s12967-014-0262-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4182814/
https://www.ncbi.nlm.nih.gov/pubmed/25245327
http://dx.doi.org/10.1186/s12967-014-0262-6

Ejemplares similares